Cargando…

Orthopox viruses and the safety margins of solvent‐detergent treated plasma‐derived medicinal products

BACKGROUND: The currently ongoing outbreak of monkeypox virus in many non‐endemic countries around the world has also raised concerns about the safety of plasma‐derived medicinal products. Based on what is known about the poxviridae, that is, that members are exceedingly large and carry a lipid enve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kindermann, Johanna, Karbiener, Michael, Kreil, Thomas R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087500/ https://www.ncbi.nlm.nih.gov/pubmed/36146943 http://dx.doi.org/10.1111/trf.17131

Ejemplares similares

Detergent-Mediated Virus Inactivation in Biotechnological Matrices: More than Just CMC
por: Farcet, Jean-Baptiste, et al.
Publicado: (2023)

Synthesis of “Nereid,” a new phenol‐free detergent to replace Triton X‐100 in virus inactivation
por: Farcet, Jean‐Baptiste, et al.
Publicado: (2020)

Orthopox simiae muscle abscess
por: Brehm, Thomas Theo, et al.
Publicado: (2022)

Risk for Hepatitis E Virus Transmission by Solvent/Detergent–Treated Plasma
por: Gallian, Pierre, et al.
Publicado: (2020)

Solvent/detergent plasma: pharmaceutical characteristics and clinical experience
por: Liumbruno, Giancarlo Maria, et al.
Publicado: (2014)

Omicron Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Immunoglobulin Preparations Manufactured From Plasma Collected in the United States and Europe( )
por: Farcet, Maria R, et al.
Publicado: (2022)

Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected During the 2020 Pandemic( )
por: Farcet, Maria R, et al.
Publicado: (2021)

Safety and tolerability of solvent/detergent‐treated plasma for pediatric patients requiring therapeutic plasma exchange: An open‐label, multicenter, postmarketing study
por: Josephson, Cassandra D., et al.
Publicado: (2021)

Evaluation of 16 molecular assays for the detection of orthopox and mpox viruses
por: Papadakis, Georgina, et al.
Publicado: (2023)

No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic
por: Schwaiger, Julia, et al.
Publicado: (2020)

Frozen and freeze‐dried solvent/detergent treated plasma: Two different pharmaceutical formulations with comparable quality
por: Heger, Andrea, et al.
Publicado: (2022)

SARS-CoV-2 and the safety margins of cell-based biological medicinal products
por: Modrof, Jens, et al.
Publicado: (2020)

Structure-Based Design, Synthesis, and Biological Evaluation of the Cage–Amide Derived Orthopox Virus Replication Inhibitors
por: Mozhaitsev, Evgenii S., et al.
Publicado: (2022)

SARS-coronavirus (SARS-CoV) and the safety of a solvent/detergent (S/D) treated immunoglobulin preparation
por: Rabenau, H.F., et al.
Publicado: (2005)

Plasma from post-COVID-19 and COVID-19-Vaccinated Donors Results in Highly Potent SARS-CoV-2 Neutralization by Intravenous Immunoglobulins
por: Karbiener, Michael, et al.
Publicado: (2021)

Antiviral activity of cyclopentenyl nucleosides against orthopox viruses (Smallpox, monkeypox and cowpox)
por: Chu, C.K, et al.
Publicado: (2003)

Transition from fresh frozen plasma to solvent/detergent plasma in the Netherlands: comparing clinical use and transfusion reaction risks
por: Saadah, Nicholas H., et al.
Publicado: (2020)

Reported transfusion‐related acute lung injury associated with solvent/detergent plasma – A case series
por: Klanderman, Robert B., et al.
Publicado: (2022)

A Novel Highly Reproducible and Lethal Nonhuman Primate Model for Orthopox Virus Infection
por: Kramski, Marit, et al.
Publicado: (2010)

Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines
por: Karbiener, Michael, et al.
Publicado: (2022)

Identification of Binding Sites for Neutralizing Monoclonal Antibodies on the 14-kDa Fusion Protein of Orthopox Viruses
por: Meyer, Hermann, et al.
Publicado: (1994)

Solvent-detergent plasma: use in neonatal patients, in adult and paediatric patients with liver disease and in obstetric and gynaecological emergencies
por: Chekrizova, V, et al.
Publicado: (2006)

Plasma procurement and plasma product safety in light of the COVID‐19 pandemic from the perspective of the plasma industry
por: Turecek, Peter L., et al.
Publicado: (2022)

Solvent/Detergent-Treated Plasma in the Management of Pediatric Patients Who Require Replacement of Multiple Coagulation Factors: An Open-Label, Multicenter, Post-marketing Study
por: Spinella, Philip C., et al.
Publicado: (2020)

Feasibility of identifying plasma donors with high measles neutralizing antibody concentrations for the use of producing a measles hyperimmune globulin for postexposure prophylaxis
por: Lackner, Cornelia, et al.
Publicado: (2022)

The Inactivation by Organic Solvents and Detergents of Partially Purified Rous I Virus Preparations
por: Drayton, H. A.
Publicado: (1961)

Validation of a pan-orthopox real-time PCR assay for the detection and quantification of viral genomes from nonhuman primate blood
por: Mucker, Eric M., et al.
Publicado: (2017)

Evaluation of the Tetracore Orthopox BioThreat(®) antigen detection assay using laboratory grown orthopoxviruses and rash illness clinical specimens
por: Townsend, Michael B., et al.
Publicado: (2013)

Jatropha Oil Derived Sophorolipids: Production and Characterization as Laundry Detergent Additive
por: Joshi-Navare, Kasturi, et al.
Publicado: (2013)

Production of a Solvent, Detergent, and Thermotolerant Lipase by a Newly Isolated Acinetobacter sp. in Submerged and Solid-State Fermentations
por: Khoramnia, Anahita, et al.
Publicado: (2011)

Measuring the effectiveness of gaseous virus disinfectants
por: Knotzer, Simone, et al.
Publicado: (2015)

Plasma Exchange Therapy Using Solvent Detergent-Treated Plasma: An Observational Pilot Study on Complement, Neutrophil and Endothelial Cell Activation in a Case Series of Patients Suffering from Atypical Hemolytic Uremic Syndrome
por: de Wit, Yasmin, et al.
Publicado: (2022)

MI (2-methyl-4-isothiazolin-3-one) contained in detergents is not detectable in machine washed textiles
por: Hofmann, Maja A., et al.
Publicado: (2018)

Incidence of transfusion‐related acute lung injury temporally associated with solvent/detergent plasma use in the ICU: A retrospective before and after implementation study
por: Klanderman, Robert B., et al.
Publicado: (2022)

Handbook of detergents /
Publicado: (1999)

Characterization of 100 sequential SARS‐CoV‐2 convalescent plasma donations
por: Jungbauer, Christof, et al.
Publicado: (2020)

Purification and Characterization of Organic Solvent and Detergent Tolerant Lipase from Thermotolerant Bacillus sp. RN2
por: Kanjanavas, Pornpimon, et al.
Publicado: (2010)

Function matters: Coronavirus cross-binding antibodies do not cross-neutralize
por: Farcet, Maria R., et al.
Publicado: (2022)

Challenges for Plasma-Derived Medicinal Products
por: Strengers, Paul F.W.
Publicado: (2023)

Calcium Binding and Tension Development in Detergent-Treated Muscle Fibers
por: Orentlicher, M., et al.
Publicado: (1974)

Cannot write session to /tmp/vufind_sessions/sess_on463ec6rco5tc190jot9a6eou